Publications by authors named "Terri Hunter"

Claim this Profile
P
Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma.
Ben C Creelan, Scott Antonia, David Noyes, Terri B Hunter, George R Simon

J Immunother· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.
Terri B Hunter, Neil J Manimala, Kimberly A Luddy, Tracy Catlin, Scott J Antonia

Anticancer Res· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice.
Rupal Ramakrishnan, Deepak Assudani, Srinivas Nagaraj, Terri Hunter, Hyun-Il Cho

J Clin Invest· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma.
Mayer Fishman, Terri B Hunter, Hatem Soliman, Patricia Thompson, Mary Dunn

J Immunother· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A GM-CSF/CD40L producing cell augments anti-tumor T cell responses.
Sophie Dessureault, Marwan Alsarraj, Susan McCarthy, Terri Hunter, David Noyes

J Surg Res· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis